To further explore the relationship between SIRT6 and prognosis in lung cancer patients, Kaplan–Meier Plotter was used to analyze survival data, and the results showed that SIRT6 upregulation was significantly associated with poor overall survival in patients with lung cancer (mOS: 59.11 months vs. Here, SIRT6 is linked to lung carcinoma.